Tectonic Therapeutic | AVRO - Należności Handlowe





Należności Handlowe Zmiana Data
Akebia Therapeutics USD 47.03M 19.19M 2025-12
Alnylam Pharmaceuticals USD 777.57M 187.2M 2025-12
Celltrion KRW 1.51T 128.69B 2025-09
Cspc Pharmaceutical CNY 8.79B 64.64M 2025-12
Deva Holding AS TRY 3.03B 343.23M 2023-09
Dianthus Therapeutics USD 52K 4.95M 2025-12
Divis Laboratories Ltd INR 26.28B 1.16B 2025-09
Gilead Sciences USD 4.91B 182M 2025-12
Ionis Pharmaceuticals USD 66M 41.39M 2025-12
Kangmei Pharma CNY 3.15B 295.48M 2025-09
Karyopharm Therapeutics USD 26.18M 5.6M 2025-12
Knight Therapeutics CAD 183M 7.46M 2025-12
Laboratorios Farma EUR 143.38M 16.93M 2023-12
MacroGenics USD 13.37M 55.86M 2025-12
Malin Corporation EUR 500K 300K 2024-12
Medical Developments International AUD 7.48M 174K 2025-12
Neuren Pharmaceuticals AUD 26.54M 5.83M 2025-12
Organigram Holdings CAD 49.94M 14.92M 2025-12
Ovoca Bio EUR 39K 408K 2025-06
Pfizer USD 18.12B 2.02B 2025-09
Pharma Mar EUR 60.6M 18.83M 2025-12
Qiagen NV USD 402.61M 9.05M 2025-12
Roche Holding CHF 11.9B 460M 2025-12
Sangamo BioSciences USD 581K 110K 2024-06
Sanofi EUR 482M 85M 2026-03
Sarepta Therapeutics USD 398.23M 2.49M 2025-12
Sartorius EUR 366.6M 74.9M 2026-03
Sino Biopharmaceutical CNY 8.45B 3.18B 2025-06
Takeda JPY 757.92B 55.68B 2025-12
Tilray USD 109.07M 2M 2025-09
Zealand Pharma A/S 340M 94.1M 2025-12
Zz Pientze Pharmaceu CNY 1.12B 222.78M 2025-09